[1]
Ortega Moreno L, Navarro Sánchez P, Abalo R. Lipidomics As Tools For Finding Biomarkers Of Intestinal Pathology: From Irritable Bowel Syndrome To Colorectal Cancer. Current drug targets 2021.
[2]
Yarla N, Madka V, Rao C. Targeting triglyceride metabolism for colorectal cancer prevention and therapy. Current drug targets 2021.
[3]
Monchusi B, Kaur M. miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to overcome Drug Resistance in Cancer. Current drug targets 2021.
[4]
Majchrzak K, Piotrowska M, Krajewska J, Fichna J. Adipocyte fatty acid binding protein (A-FABP) as a potential new therapeutic target for treatment of obesity - associated cancers. Current drug targets 2021.
[5]
Vishwakarma S, Arya N, Kumar A. Regulation of tumor immune microenvironment by sphingolipids and lysophosphatidic acid. Current drug targets 2021.
[6]
Srivastava A, Srivastava P, Mathur S, Abbas S, Rai N, Tiwari S, et al. Lipid metabolism and mitochondria: Cross talk in cancer. Current drug targets 2021.